Windlas Biotech Limited — Others, 29-07-2025: Shareholders meeting

Windlas Biotech's 24th Annual General Meeting concluded with all resolutions receiving shareholder approval. Key outcomes include the adoption of the company's annual financial results and the declaration of a final dividend of Rs. 5.80 per equity share for FY25. Shareholders also approved the re-appointment of Executive Director Mr. Pawan Kumar Sharma and the appointment of new Statutory and Secretarial Auditors. Additionally, the 'Windlas Plan 2025,' a scheme for granting units to eligible employees, was approved, signaling a strategic focus on staff incentives.